Akamine Scott's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Dec 7, 2023
- Accession no.
- 0000950170-23-068887
- Filed
- Dec 7, 2023
- Trade date
- Dec 5-7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $676.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akamine ScottCIK 0001816720 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | Common Stock | MOption exerciseAcquired | +7,500 | $13.17 | +$98,775 | 8,013 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −7,500 | $35.00 | −$262,500 | 513 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +10,000 | $13.17 | +$131,700 | 10,513 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −10,000 | $41.37 | −$413,700 | 513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 264,262 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 254,262 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.